GSK plc, the global pharmaceutical and healthcare company listed in London, has published its provisional dividend calendar for 2027, covering all four quarterly distributions through to April 2028. The announcement, made on 6 November 2026 and signed by Company Secretary V A Whyte, sets out indicative ex-dividend, record, and payment dates for ordinary shareholders and American Depositary Share holders alike. The disclosure gives income-focused investors advance visibility of the schedule, though GSK has cautioned that all dates remain subject to change. Investors who participate in GSK's Dividend Reinvestment Plan (DRIP) will also note specific election deadlines for each quarter.
Key Points
- GSK plc (GSK) — global pharmaceutical and consumer healthcare group listed on the London Stock Exchange
- GSK has published provisional quarterly dividend dates covering Q1 through Q4 2027, with the final payment falling in April 2028
- Q1 2027 results are due 28 April 2027; ordinary shares go ex-dividend 13 May 2027, with payment on 15 July 2027
- Investors should monitor whether these provisional dates are confirmed or revised ahead of each quarterly results announcement
GSK's Full 2027 Provisional Dividend Calendar: Quarter-by-Quarter Dates
The announcement sets out four sets of dates spanning 2027 and into early 2028. For Q1 2027, results are scheduled for 28 April 2027, with ordinary shares going ex-dividend on 13 May and payment on 15 July 2027. Q2 2027 results follow on 28 July 2027, with an ex-dividend date of 12 August and payment on 14 October 2027. Q3 2027 results are expected 27 October 2027, with payment on 13 January 2028. The Q4 2027 cycle concludes with results on 2 February 2028 and a final payment date of 13 April 2028, completing the full annual distribution schedule.
American Depositary Share Holders Face Separate Ex-Dividend Dates Under GSK's 2027 Schedule
GSK maintains a dual structure for dividend entitlements, reflecting its listing on both the London Stock Exchange and in the United States via American Depositary Shares. For each quarter in 2027, the ADS ex-dividend date falls one day after the ordinary share ex-dividend date. For example, in Q1 2027 ordinary shares go ex-dividend on Thursday 13 May, whilst ADS holders' ex-dividend date is Friday 14 May — a date that also coincides with the record date for that quarter. This distinction is relevant for international investors who hold GSK exposure through the US-listed depositary structure rather than directly on the London market.
DRIP Election Deadlines Give GSK Shareholders Advance Notice for Reinvestment Planning
GSK operates a Dividend Reinvestment Plan, and the announcement specifies the last date for DRIP elections for each quarter. In Q1, Q2, and Q4 2027, the DRIP deadline aligns with the record date, whilst in Q3 2027 the last election date also falls on Friday 12 November 2027, the same day as both the ex-dividend and record dates. Shareholders wishing to reinvest dividends in additional GSK ordinary shares must ensure elections are submitted by each respective deadline. No dividend amounts or yield figures were disclosed in this announcement.
All 2027 Dividend Dates Remain Provisional and Subject to Revision by GSK
GSK has explicitly stated that all dates published in this calendar are indicative and may be subject to change, a standard caveat for forward-looking corporate calendars of this nature. The company did not disclose dividend quantum, payout ratios, or any commentary on the financial outlook alongside this announcement. Investors relying on these dates for income planning or trading strategies around ex-dividend periods should monitor subsequent GSK regulatory announcements for any revisions. The provisional nature of the schedule is a company-specific risk that income investors will wish to factor into their planning ahead of each quarterly results cycle.




Please wait processing your request...